Aleph (psychedelic)
{{Infobox drug
| Verifiedfields = verified
| Watchedfields = verified
| verifiedrevid = 477314818
| drug_name = Aleph
| image = 2,5-dimethoxy-4-methylthioamphetamine.svg
| width = 200px
| caption =
| pronounce =
| tradename =
| Drugs.com =
| MedlinePlus =
| licence_CA =
| licence_EU =
| DailyMedID =
| licence_US =
| pregnancy_AU =
| pregnancy_category =
| dependency_liability =
| addiction_liability =
| routes_of_administration = Oral
| class = Serotonergic psychedelic; Hallucinogen
| ATC_prefix = None
| ATC_suffix =
| legal_status =
| bioavailability =
| protein_bound =
| metabolism =
| metabolites =
| onset =
| elimination_half-life =
| duration_of_action =
| excretion =
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 61638-07-1
| PubChem = 143828
| PubChemSubstance =
| IUPHAR_ligand =
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 126887
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = C9ZVF4O01N
| KEGG =
| ChEBI =
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 447830
| NIAID_ChemDB =
| PDB_ligand =
| synonyms = Aleph; Aleph-1; ALEPH; ALEPH-1; DOT; DOT-1; 2,5-Dimethoxy-4-methylthioamphetamine; 4-Methylthio-2,5-dimethoxyamphetamine
| IUPAC_name = 1-[2,5-dimethoxy-4-(methylsulfanyl)phenyl]propan-2-amine
| C=12 | H=19 | N=1 | O=2 | S=1
| SMILES = C1(=C(C=C(C(=C1)SC)OC)CC(C)N)OC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H19NO2S/c1-8(13)5-9-6-11(15-3)12(16-4)7-10(9)14-2/h6-8H,5,13H2,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = COBYBOVXXDQRAU-UHFFFAOYSA-N
}}
Aleph, or Aleph-1, also known as DOT or as 4-methylthio-2,5-dimethoxyamphetamine, is a psychedelic drug of the amphetamine and DOx families.
Effects
Aleph was first synthesized by Alexander Shulgin, who named it after the first letter of the Hebrew alphabet. In his book PiHKAL, Shulgin lists the dosage range as 5 to 10{{nbsp}}mg, with effects typically lasting for 6 to 8{{nbsp}}hours.{{CitePiHKAL}}
Pharmacology
Like many other psychedelics, Aleph is a partial agonist at the 5-HT2A receptor (EC50 = 10 nM).{{cite journal | vauthors = Halberstadt AL, Luethi D, Hoener MC, Trachsel D, Brandt SD, Liechti ME | title = Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines | journal = Psychopharmacology | volume = 240 | issue = 1 | pages = 115–126 | date = January 2023 | pmid = 36477925 | pmc = 9816194 | doi = 10.1007/s00213-022-06279-2 }}{{cite journal | vauthors = Halberstadt AL, Luethi D, Hoener MC, Trachsel D, Brandt SD, Liechti ME | title = Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines | journal = Psychopharmacology (Berl) | volume = 240 | issue = 1 | pages = 115–126 | date = January 2023 | pmid = 36477925 | pmc = 9816194 | doi = 10.1007/s00213-022-06279-2 | url = https://core.ac.uk/download/pdf/543784099.pdf}} It has weak MAO-A inhibitory activity with an IC50 of 5.2 μM. For reference, amphetamine has an IC50 of 11 μM and 4-methylthioamphetamine has a value of 0.2 μM.{{cite journal | vauthors = Gallardo-Godoy A, Fierro A, McLean TH, Castillo M, Cassels BK, Reyes-Parada M, Nichols DE | title = Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling | journal = Journal of Medicinal Chemistry | volume = 48 | issue = 7 | pages = 2407–2419 | date = April 2005 | pmid = 15801832 | doi = 10.1021/jm0493109 }}
Homologues
=Aleph-2=
{{Main|Aleph-2}}
Image:2,5-dimethoxy-4-ethylthioamphetamine.svg {{Clear|left}}
Dosage: 4–8 mg
Duration: 8–16 hours
Effects: Strong visuals
CAS number: 185562-00-9
SMILES: C1(=C(C=C(C(=C1)SCC)OC)CC(C)N)OC
=Aleph-4=
Image:Aleph-4.svg {{Clear|left}}
Dosage: 7–12 mg
Duration: 12–20 hours
Effects: "profound and deep learning experiences" - Alexander Shulgin
CAS number: 123643-26-5
SMILES: C1(=C(C=C(C(=C1)SC(C)C)OC)CC(C)N)OC
=Aleph-6=
Image:Aleph-6.svg {{Clear|left}}
Dosage: 40 mg or more
Duration: very long, unspecified
Effects: enhances other psychoactive drugs, similar to 2C-D
2C analog: 2C-T-6 (has never been synthesized){{Citation needed|date=August 2023}}
CAS number: 952006-44-9
SMILES: C1(=C(C=C(C(=C1)SC2=CC=CC=C2)OC)CC(C)N)OC=DSC4
R=5SC456
=Aleph-7=
Image:2,5-dimethoxy-4-propylthioamphetamine.svg {{Clear|left}}
Dosage: 4–7 mg
Duration: 15–30 hours
CAS number: 207740-16-7
SMILES: C1(=C(C=C(C(=C1)SC4^4
Legal status
=United States=
In the United States, Aleph is a Schedule 1 controlled substance as a positional isomer of 2C-T-4 and 2C-T-7.{{cite web | title = Lists of: Scheduling Actions Controlled Substances Regulated Chemicals | url = https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf | date = January 2023 | work = Drug and Chemical Evaluation Section, Diversion Control Division | publisher = Drug Enforcement Administration, U.S. Department of Justice }}
See also
References
{{Reflist}}
External links
- [http://www.erowid.org/library/books_online/pihkal/pihkal003.shtml Aleph Entry in PiHKAL]
- [https://isomerdesign.com/pihkal/read/pk/3 ALEPH Entry at PiHKAL·info]
- [http://www.erowid.org/library/books_online/pihkal/pihkal004.shtml Aleph-2 Entry in PiHKAL]
- [https://isomerdesign.com/pihkal/read/pk/4 ALEPH-2 Entry at PiHKAL·info]
- [http://www.erowid.org/library/books_online/pihkal/pihkal005.shtml Aleph-4 Entry in PiHKAL]
- [https://isomerdesign.com/pihkal/read/pk/5 ALEPH-4 Entry at PiHKAL·info]
- [http://www.erowid.org/library/books_online/pihkal/pihkal006.shtml Aleph-6 Entry in PiHKAL]
- [https://isomerdesign.com/pihkal/read/pk/6 ALEPH-6 Entry at PiHKAL·info]
- [http://www.erowid.org/library/books_online/pihkal/pihkal007.shtml Aleph-7 Entry in PiHKAL]
- [https://isomerdesign.com/pihkal/read/pk/7 ALEPH-7 Entry at PiHKAL·info]
- [https://tripsitter.com/amphetamines/aleph-6/ Aleph-6: Pharmacology, Side Effects, & Characteristics - Tripsitter]
{{Psychedelics}}
{{Serotonin receptor modulators}}
{{Phenethylamines}}
{{Chemical classes of psychoactive drugs}}